INSMED, INC.
NASDAQ:INSM
$4.84
-$0.16
(-3.20%)
Quote as of 3:27 PM EST on 02/10/12
Related Resources
INSM
vs. S&P 500
|
$4.84
-$0.16
(-3.20%)
|
|
| Today's Open | $4.94 |
|---|---|
| Previous Close | $5.00 |
| Daily Range | $4.83 - $5.03 |
| 52-Week Range | $2.64 - $13.50 |
| Market Cap | $120.19M |
| P/E Ratio | -1.61 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 60,746 |
| Average Daily Volume | 217,940 |
| Current FY EPS | -$2.65 |
INSM Information
| Description |
|---|
| A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Merck Reports Strong Q3 Results on Gardasil and Diabetes Med
11/6/2011 by Nasdaq
10/11/2011 by DailyFinance
3 Stocks Approaching Greatness
9/19/2011 by DailyFinance
8/31/2011 by DailyFinance
Hidden Stocks for High Returns
8/19/2011 by DailyFinance
Thursday's Top Performing Small Cap Stocks (AONE, AIQ, KV.A, INSM, CXPO)
8/12/2011 by Nasdaq
Whoa! What Just Happened to My Stock?
8/12/2011 by DailyFinance
Aeterna Zentaris: Out of Sight, Out of Mind
8/11/2011 by DailyFinance
8/3/2011 by Rich Duprey
FDA Halts Insmed Study After Rat Tests, Asks For More Data
8/2/2011 by Smart Money
